Logan G Spector1, Jeremiah S Menk2, Jessica H Knight3, Courtney McCracken3, Amanda S Thomas3, Jeffrey M Vinocur4, Matthew E Oster3, James D St Louis5, James H Moller6, Lazaros Kochilas7. 1. Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. 2. Biostatistical Design and Analysis Center, University of Minnesota, Minneapolis, Minnesota. 3. Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia. 4. Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York. 5. Department of Pediatric Surgery, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri. 6. Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota. 7. Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: lazaros.kochilas@emory.edu.
Abstract
BACKGROUND: Congenital heart surgery has improved the survival of patients with even the most complex defects, but the long-term survival after these procedures has not been fully described. OBJECTIVES: The purpose of this study was to evaluate the long-term survival of patients (age <21 years) who were operated on for congenital heart defects (CHDs). METHODS: This study used the Pediatric Cardiac Care Consortium data, a U.S.-based, multicenter registry of pediatric cardiac surgery. Survival analysis included 35,998 patients who survived their first congenital heart surgery at <21 years of age and had adequate identifiers for linkage with the National Death Index through 2014. Survival was compared to that in the general population using standardized mortality ratios (SMRs). RESULTS: After a median follow-up of 18 years (645,806 person-years), 3,191 deaths occurred with an overall SMR of 8.3 (95% confidence interval [CI]: 8.0 to 8.7). The 15-year SMR decreased from 12.7 (95% CI: 11.9 to 13.6) in the early era (1982 to 1992) to 10.0 (95% CI: 9.3 to 10.8) in the late era (1998 to 2003). The SMR remained elevated even for mild forms of CHD such as patent ductus arteriosus (SMR 4.5) and atrial septal defects (SMR 4.9). The largest decreases in SMR occurred for patients with transposition of great arteries (early: 11.0 vs. late: 3.8; p < 0.05), complete atrioventricular canal (31.3 vs. 15.3; p < 0.05), and single ventricle (53.7 vs. 31.3; p < 0.05). CONCLUSIONS: In this large U.S. cohort, long-term mortality after congenital heart surgery was elevated across all forms of CHD. Survival has improved over time, particularly for severe defects with significant changes in their management strategy, but still lags behind the general population.
BACKGROUND: Congenital heart surgery has improved the survival of patients with even the most complex defects, but the long-term survival after these procedures has not been fully described. OBJECTIVES: The purpose of this study was to evaluate the long-term survival of patients (age <21 years) who were operated on for congenital heart defects (CHDs). METHODS: This study used the Pediatric Cardiac Care Consortium data, a U.S.-based, multicenter registry of pediatric cardiac surgery. Survival analysis included 35,998 patients who survived their first congenital heart surgery at <21 years of age and had adequate identifiers for linkage with the National Death Index through 2014. Survival was compared to that in the general population using standardized mortality ratios (SMRs). RESULTS: After a median follow-up of 18 years (645,806 person-years), 3,191 deaths occurred with an overall SMR of 8.3 (95% confidence interval [CI]: 8.0 to 8.7). The 15-year SMR decreased from 12.7 (95% CI: 11.9 to 13.6) in the early era (1982 to 1992) to 10.0 (95% CI: 9.3 to 10.8) in the late era (1998 to 2003). The SMR remained elevated even for mild forms of CHD such as patent ductus arteriosus (SMR 4.5) and atrial septal defects (SMR 4.9). The largest decreases in SMR occurred for patients with transposition of great arteries (early: 11.0 vs. late: 3.8; p < 0.05), complete atrioventricular canal (31.3 vs. 15.3; p < 0.05), and single ventricle (53.7 vs. 31.3; p < 0.05). CONCLUSIONS: In this large U.S. cohort, long-term mortality after congenital heart surgery was elevated across all forms of CHD. Survival has improved over time, particularly for severe defects with significant changes in their management strategy, but still lags behind the general population.
Authors: M S Connelly; G D Webb; J Somerville; C A Warnes; J K Perloff; R R Liberthson; F J Puga; R L Collins-Nakai; W G Williams; L A Mercier; V F Huckell; J P Finley; R McKay Journal: Can J Cardiol Date: 1998-03 Impact factor: 5.223
Authors: Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa Journal: Pediatrics Date: 2013-04-22 Impact factor: 7.124
Authors: Matthew S Yong; Deane Yim; Christian P Brizard; Terry Robertson; Andrew Bullock; Yves d'Udekem; Igor E Konstantinov Journal: Ann Thorac Surg Date: 2014-03-15 Impact factor: 4.330
Authors: Michelle Gurvitz; Kristin M Burns; Ralph Brindis; Craig S Broberg; Curt J Daniels; Stephanie M P N Fuller; Margaret A Honein; Paul Khairy; Karen S Kuehl; Michael J Landzberg; William T Mahle; Douglas L Mann; Ariane Marelli; Jane W Newburger; Gail D Pearson; Randall C Starling; Glenn R Tringali; Anne Marie Valente; Joseph C Wu; Robert M Califf Journal: J Am Coll Cardiol Date: 2016-04-26 Impact factor: 24.094
Authors: Jeffrey Phillip Jacobs; Sean M O'Brien; Sara K Pasquali; Marshall Lewis Jacobs; François G Lacour-Gayet; Christo I Tchervenkov; Erle H Austin; Christian Pizarro; Kamal K Pourmoghadam; Frank G Scholl; Karl F Welke; J William Gaynor; David R Clarke; John E Mayer; Constantine Mavroudis Journal: Ann Thorac Surg Date: 2012-06-15 Impact factor: 4.330
Authors: Sara K Pasquali; Jeffrey P Jacobs; Gregory K Farber; David Bertoch; Elizabeth D Blume; Kristin M Burns; Robert Campbell; Anthony C Chang; Wendy K Chung; Tiffany Riehle-Colarusso; Lesley H Curtis; Christopher B Forrest; William J Gaynor; Michael G Gaies; Alan S Go; Paul Henchey; Gerard R Martin; Gail Pearson; Victoria L Pemberton; Steven M Schwartz; Robert Vincent; Jonathan R Kaltman Journal: Circulation Date: 2016-04-05 Impact factor: 29.690
Authors: Katie M Moynihan; Jennifer M Snaman; Erica C Kaye; Wynne E Morrison; Aaron G DeWitt; Loren D Sacks; Jess L Thompson; Jennifer M Hwang; Valerie Bailey; Deborah A Lafond; Joanne Wolfe; Elizabeth D Blume Journal: Pediatrics Date: 2019-08 Impact factor: 7.124
Authors: Clayton A Smith; Courtney McCracken; Amanda S Thomas; Logan G Spector; James D St Louis; Matthew E Oster; James H Moller; Lazaros Kochilas Journal: JAMA Cardiol Date: 2019-01-01 Impact factor: 14.676
Authors: Lydia K Wright; Jessica H Knight; Amanda S Thomas; Matthew E Oster; James D St Louis; Lazaros K Kochilas Journal: Heart Date: 2019-02-02 Impact factor: 5.994
Authors: Chizitam Ibezim; Amber Leila Sarvestani; Jessica H Knight; Omar Qayum; Noor Alshami; Elizabeth Turk; James St Louis; Courtney McCracken; James H Moller; Lazaros Kochilas; Geetha Raghuveer Journal: Ann Thorac Surg Date: 2018-09-26 Impact factor: 4.330
Authors: Matthew E Fasano-McCarron; Jane Holmes Bernstein; Deborah P Waber; Jane W Newburger; David R DeMaso; David C Bellinger; Adam R Cassidy Journal: J Int Neuropsychol Soc Date: 2021-01-14 Impact factor: 2.892